Clinicians’ Perspectives on the Impact of Different Attributes of Androgen Receptor Pathway Inhibitors on Prostate Cancer Treatment Preferences and Compliance in Mexico

Oncology and Therapy · Published 2026-07-23 · DOI 10.1007/s40487-026-00457-4

Free full text

Authors (8)

Mario Escobar Gómez, Ana Maria Rodríguez-Leboeuf, Selene Camargo-Correa, Ida Caterina García-Appendini, Arti Dhar, Isabela Rivas, Juan Guillermo Ariza, Pedro A. Madero-Morales

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Gómez, M., Rodríguez-Leboeuf, A., Camargo-Correa, S., et al. (2026). Clinicians’ Perspectives on the Impact of Different Attributes of Androgen Receptor Pathway Inhibitors on Prostate Cancer Treatment Preferences and Compliance in Mexico. Oncology and Therapy. https://doi.org/10.1007/s40487-026-00457-4

Related articles

• Abemaciclib Persistence in Patients with HR+, HER2−, Node-Positive Early Breast Cancer: a Real-World Analysis · Oncology and Therapy · 2025 · Same journal
• A Comprehensive Review of the Role of Zanubrutinib for Patients with Chronic Lymphocytic Leukemia · Oncology and Therapy · 2026 · Same journal
• Gastroenteropancreatic Neuroendocrine Carcinoma (GEP-NEC): An Aggressive Disease Course and Limitations for Personalized Oncology · Oncology and Therapy · 2026 · Same journal
• The Immuno-oncology-Induced Cytokine Release Syndrome Patient Diary: A Content-Valid, Patient-Reported Outcome Measure · Oncology and Therapy · 2025 · Same journal
• Expression of Prostate-Specific Membrane Antigen in Salivary Gland Tumors · Oncology and Therapy · 2025 · Same journal
• Application and Progress of Antibody-Drug Conjugates (ADCs) in the Treatment of Metastatic Triple-Negative Breast Cancer · Oncology and Therapy · 2025 · Same journal
• Real-World Epidemiology, Clinical Characteristics and Outcomes of Women with Germline BRCA Mutation and Early Breast Cancer in China · Oncology and Therapy · 2025 · Same journal
• Cost-effectiveness of Nivolumab + Platinum Doublet Chemotherapy as Neoadjuvant Treatment for Resectable Non-Small Cell Lung Cancer in England · Oncology and Therapy · 2025 · Same journal
• Qualitative Interviews on the Experience of Orally vs. Intramuscularly Administered Endocrine Therapy for Advanced Breast Cancer: Patient and Healthcare Provider Perspectives · Oncology and Therapy · 2025 · Same journal
• Patient and Physician Perspectives on Multiple Myeloma Data Presented at ASCO and EHA 2025: A Podcast · Oncology and Therapy · 2025 · Same journal